Latest colorectal News | Page 2

Common inexpensive drug halves recurrence in colorectal cancer
Common and inexpensive medicine halves the risk of recurrence in patients with colorectal cancer
Why have cancer survival rates stopped improving in the UK?
Launceston General Hospital welcomes state-of-the-art surgical robot
Rising Colorectal Cancer Among Young Adults In Sweden
Hidden Bowel Cancer Risk In Common Growths
Single Port Robot Australian-first At Epworth Richmond
New $7 million research initiative to help tackle early-onset cancer
Pruritus And Psychiatry By Kealey Griffiths
Thesis on clinically reliable artificial intelligence for prostate cancer pathology
Serap’s From terminal diagnosis to Cancer Council volunteer 
Regulatory DNA Links Cancer And Tissue Regeneration
Don’t let embarrassment stop you – talking about these anal cancer symptoms could save your life
Epworth Freemasons At Top Tier Of Robotic Surgery
What You Need To Know About Early Onset Colon Cancer
First Robotic Chest Surgery For Epworth Eastern
US University Joins Chimeric’s CHM CDH17 Clinical Trial
Tim’s How music helped him navigate his cancer experience
Results Of ALASCCA Study Will Be Presented At ASCO-GI
Most adults will gain half a kilo this year – and every year. Here’s how to stop ‘weight creep’
Dr Shane Reti: National delivers first cancer medicines from $604m boost
The Swedish Cancer and Allergy Fund grants SEK 2.3 million to KI researchers
Claus for concern: why we should be worried about Santa’s health
FivepHusion secures ethics approval of a Phase 1b deflexifol clinical trial
DNA Secreted By Tumor Cell Prompts Immune Response
First molecule identified that promotes gut healing while inhibiting tumour progression
Support for state-of-the-art cancer research projects
Increased medicines access continues following budget boost
Bowel Cancer Breakthrough
Too much lactate can harm our health – these microbes in our gut keep it in check
Chimeric says cancer patient achieves complete response in CHM CORE-NK trial
For 50,000 Australians October 5 is the one day each year when they can be seen and heard
Surgical researchers compete for Louis Barnett Prize 2024
Considering race in colon cancer prediction reduces disparities
Asbestos study highlights risk of ACT residents developing cancer
Hon Dr Shane Reti: National delivers first cancer medicines from $604m boost
New knowledge about cell receptors paves the way for new drugs against intestinal tumours
Chimeric says first patient dosed in trial of CDH17-directed CAR-T cell therapy
Caroline Nordenvall awarded twice at the Surgeons’ Week 2024
All the reasons a cup of coffee really can be good for you
Chimeric says Phase 1/2 CHM CDH17 CAR-T GMP manufacturing complete
Dan L Duncan Comprehensive Cancer Center launches Phase 1 Clinical Trial Program
Riding High After Robotic Surgery
Chimeric Therapeutics says first patient enrolled in cell therapy trial
National Bowel Screening Programme reaches 2 million life-saving screening kits
Promising Role Of Antidiabetic Drug In Cancer Control
How Research In Common Cancers Is Helping Rare Cancers
Identifying the initial steps in colorectal cancer formation